RN7SL155P

Across TCGA pan-cancer cohorts, RN7SL155P RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated RN7SL155P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL155P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL155P expression acts as an unfavorable survival marker, although some lineages such as HNSC and KIRP show a favorable association.

HNSC, LUSC, and KIRC are the cancer types where RN7SL155P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.761	0.331	.001	144	view →
LUSC	DFS	Tertile	II,III,IV	0.175	0.413	.004	48	view →
KIRC	DFS	Tertile	IV	0.258	0.521	.014	36	view →
KIRP	DFS	Tertile	II,III,IV	1.000	0.636	.027	21	view →
BLCA	DFS	Tertile	All	0.165	0.503	.030	18	view →
PCPG	OS	Tertile	All	0.714	0.963	<.001	18	view →
THYM	OS	Tertile	All	0.381	0.879	.003	12	view →
READ	OS	Tertile	III,IV	0.287	0.772	.030	9	view →
THCA	DFS	Tertile	All	1.000	0.934	.030	9	view →
MESO	OS	Tertile	III,IV	0.312	0.576	.026	9	view →
LIHC	DFS	Tertile	All	0.633	0.272	.014	9	view →
OV	DFS	Tertile	III,IV	0.254	0.143	.046	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 15 lineages.

RN7SL155P–HNSC (OS)

Open the HNSC breakdown →